On October 19, the Bright Future Fund, in collaboration with Roche Pharma Vietnam, celebrated the kick-off event for "Joining hands for the women I love" campaign 2023 to raise awareness about breast cancer and improve women’s health.
This campaign commemorates the 10th anniversary of Roche's partnership with the Vietnamese healthcare sector in their joint efforts to enhance women's health since 2013.
"This health campaign specifically targets Vietnamese women and has had a significant impact in recent years," said Minister of Health Dao Hong Lan during the launch ceremony.
"It equips women with knowledge and urges them to proactively take care of themselves by actively screening for early detection of breast cancer. I call upon the community to join hands in pushing back against breast cancer. Businesses and organisations should implement screening programmes for cancer, particularly breast cancer, as part of regular health check-ups for women over 40 years old, aiming towards a strong and healthy Vietnam."
This year, a nationwide initiative has been launched to offer support to breast cancer patients. The "Breast Cancer Patient Forum" programme is being held in Hanoi and Ho Chi Minh City, providing patients with valuable advice, accurate information on diagnosis and treatment, and addressing their concerns throughout the treatment process.
It also serves as a platform for patients and healthcare professionals to connect, share experiences, and find inspiration in each other's resilience and optimism. Additionally, the "Hair for Cancer Patients" activity continues to be implemented in hospitals and cancer centres across the country.
"Screening and early detection play a crucial role in the fight against breast cancer among women," said Nguyen Thi Xuyen, former Deputy Minister of Health and president of the Bright Future Fund.
"The main goal of this campaign is to empower Vietnamese women with knowledge and raise their awareness about this life-threatening disease. I urge women to prioritise their health by adopting proactive habits such as regular breast cancer screenings and following the five essential steps for early detection."
Over the past decade, this campaign has made significant progress by conducting free screenings for over 72,000 women nationwide. Numerous women have received guidance on breast care, early detection methods, effective prevention strategies, and have had their questions about breast cancer answered through the informative "Doctor Talks" programme organised by the Fund.
Furthermore, public awareness initiatives such as illuminating buildings in pink and organising double-decker bus parades have successfully captured the attention of the community and generated a positive response towards early detection of breast cancer.
"For the past decade, Roche Pharma Vietnam has been at the forefront of optimising breast cancer care through early screenings and access to innovative treatments. Today, we celebrate the 10th year anniversary of our partnership in advocating for a healthier future for women in Vietnam. We are honoured to be a part of this meaningful journey and remain dedicated to creating a positive impact in the fight against breast cancer," said Lennor Carrillo, general director of Roche Pharma Vietnam.
|K Hospital and Roche Pharma Vietnam co-organise cancer immunotherapy seminar
K Hospital, together with Roche Pharma Vietnam, have organised a highly anticipated scientific conference themed Cancer ImmunoTherapy - Light to guide the future in the treatment of lung and liver cancer.
|Urgent action needed on breast and cervical cancer
Newly launched Asia Pacific Women’s Cancer Coalition (APAC WCC) calls for a greater commitment to address the gaps to support countries in achieving their national targets for cancer prevention and control.
|Roche commitment to improving women’s cancer care
Lennor Carrillo, general director of Roche Pharma Vietnam, and Dr. Qadeer Raza, general manager of Roche Vietnam (Diagnostics), spoke with VIR's Thanh Van about the latest report of women's cancer and reiterated their commitment to women’s cancer care with their combined strength of diagnostics and pharmaceuticals.